References
- Holm-Nielsen P. Pathogenesis of ascites in peritoneal carcinomatosis. Acta Path Microbiol Scand 1953; 33: 10–21
- White M J, Miller F N, Heuser L S, Pietsch C G. Human malignant ascites and histamin-induced protein leakage from the normal microcirculation. Microvasc Res 1988; 35: 63–72
- Erdös E G. Commentary. The kinins. A status report. Biochem Pharmacol 1976; 25: 1563–9
- Colman R W. Surface-mediated defence reactions. The plasma contact activation system. J Clin Invest 1984; 73: 1249–53
- Colman R W, Schmaier A H. The contact activation system: Biochemistry and interactions of these surface-mediated defense reactions. CRC Crit Rev Oncol Hematol 1986; 5: 57–85
- Schapira M. Major inhibitors of the contact phase coagulation factors. Semin Thromb Hemost 1987; 13: 69–78
- Schapira M, Scott C F, Colman R W. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest 1982; 69: 462–8
- Kluft C, Dooijewaard G, Emeis J J. Role of the contact system in fibrinolysis. Semin Thromb Hemost 1987; 13: 50–68
- Matsumura Y, Kimura M, Yamamoto T, Maeda H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res 1988; 79: 1327–34
- Laake K, Østerud B. Activation of purified plasma factor VII by human plasmin, plasma kallikrein and activated components of the human intrinsic blood coagulation system. Thromb Res 1974; 5: 759–72
- Amundsen E, Gallimore M J, Aasen A O, Larsbraa-Ten M, Lyngaas K. Activation of human plasma prekallikrein: Influence of activators, activation time and temperature and inhibitors. Thromb Res 1978; 13: 625–36
- Aasen A O, Smith-Erichsen N, Gallimore M J, Amundsen E. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock. Adv. in Shock Res, W Schumer, J J Spitzer, B E Marshall. A.R. Liss. Inc., New York 1980; 1–11
- Kingsley G R. The determination of serum total protein, albumin, and globulin by the biuret reaction. J. Biol Chem 1939; 131: 197–200
- Aasen A O, Kierulf P, Stramme J. Methodological considerations on chromogenic peptide substrate assays and application on automated analyzers. Acta Chir Scand 1982; 17–22
- Sturzebecher J, Svendsen L, Eichenberger R, Markwardt F. A new assay for the determination of factor XII in plasma using a chromogenic substrate and a selective inhibitor of plasma kallikrein. Thromb Res 1989; 55: 709–15
- Scott C F, Colman R W. A simple and accurate microplate assay for the determination of factor XI in plasma. J Lab Clin Med 1988; 111: 708–14
- De La Cadena R A, Scott C F, Colman R W. Evaluation of a microassay for human plasma prekallikrein. J Lab Clin Med 1987; 109: 601–7
- Laurell C B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45–52
- Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
- Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4
- Chan J YC, Movat H Z. Purification of factor XII (Hageman factor) from human plasma. Thromb Res 1976; 8: 337–49
- Røise O, Sivertsen S, Ruud T E, Bouma B N, Stadaas J O, Aasen A O. Studies on components of the contact phase system in patients with advanced gastrointestinal cancer. Cancer 1990; 65: 1355–9
- Villamil F G, Sorroche P B, Aziz H F, Lopez P M, Oyhamburu J M. Ascitic fluid α1-antitrypsin. Dig Dis Sci 1990; 35: 1105–9
- Kluft C, Verheijen J H, Jie A HF, Rijken D C, Preston F E, Sue-Ling H M, Jespersen J, Aasen A O. The post-operative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45: 605–10
- Mandle R J, Kaplan A P. Hageman factor substrates. Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J Biol Chem 1977; 252: 6097–104
- Hall P L, Roberts R C. Physical and chemical properties of human plasma a2-macroglobulin. Biochem J 1978; 173: 27–38
- Karlsrud T S, Bue L, Aasen A O, Johansen H T. Characterization of kininogens in human malignant ascites. Thromb Res 1991; 63: 641–50